Angiotech Pharmaceuticals Inc - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Angiotech Pharmaceuticals Inc Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Angiotech Pharmaceuticals Inc. The Group's principal activity is to discover, develop and market innovative technologies and medical products. It operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceutical Technologies segment develops products, out-licenses technologies and markets partnerships with major medical device, pharmaceutical or biomaterials companies. The Medical Product segment manufactures and markets a wide range of single use, specialty medical devices with products focused on general surgery, oncology and tumor biopsy, interventional radiology and vascular surgery, ophthalmology and aesthetic surgery.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report